Comparative efficacy of HPV 16/18 DNA and E6/E7 mRNA testing in detecting high-grade cervical lesions (CIN2+) in women with cervical biopsies

被引:0
作者
Benvari, Sepideh [1 ]
Aslanimehr, Masoumeh [2 ]
Samiee-Rad, Fatemeh [3 ]
Naserpour-Farivar, Taghi [2 ]
Sadeghi, Hamid [2 ,4 ]
机构
[1] Univ St Andrews, Sch Med, Infect & Global Hlth Res Div, St Andrews, Scotland
[2] Qazvin Univ Med Sci, Med Microbiol Res Ctr, Qazvin, Iran
[3] Qazvin Univ Med Sci, Inst Prevent Noncommunicable Dis, Cellular & Mol Res Ctr, Qazvin, Iran
[4] Qazvin Univ Med Sci, Student Res Comm, Qazvin, Iran
关键词
Cervical cancer; E6/E7; mRNA; HPV; 16/18; Real-Time PCR; CANCER; E6; EXPRESSION; CLASSIFICATION; TRIAGE;
D O I
10.1016/j.diagmicrobio.2024.116668
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The study evaluated the efficacy of HPV 16/18 E6/E7 mRNA detection in women with abnormal cervical histology. A total of 99 cervical biopsy samples were analyzed, including 49 benign, 16 with cervical intraepithelial neoplasia grade 1 (CIN1), 9 with CIN2/3, and 25 with cervical cancers. Samples were tested for HPV 16/18 using both DNA and mRNA RT-PCR methods. The findings revealed a sensitivity of 85.3 % (29/34) for the HPV DNA test and 76.5 % (26/34) for the mRNA test in detecting CIN2+ lesions. Notably, the E6/E7 mRNA test demonstrated greater specificity for CIN2+ at 75.4 % (49/65), compared to 52.3 % (34/65) for the DNA test. The prevalence of positive results for both tests increased with the severity of squamous cell abnormalities. However, the HPV 16/18 E6/E7 mRNA test provided superior specificity, making it a more effective method for cervical cancer screening in this region, offering more precise results than DNA testing alone.
引用
收藏
页数:5
相关论文
共 55 条
[1]   Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+in young women with normal cervical cytology [J].
Al-Shibli, Khalid ;
Mohammed, Hiba Abdul Latif ;
Maurseth, Ramona ;
Fostervold, Mikkel ;
Werner, Sebastian ;
Sorbye, Sveinung Wergeland .
PLOS ONE, 2022, 17 (11)
[2]   Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [J].
Arbyn, Marc ;
Weiderpass, Elisabete ;
Bruni, Laia ;
de Sanjose, Silvia ;
Saraiya, Mona ;
Ferlay, Jacques ;
Bray, Freddie .
LANCET GLOBAL HEALTH, 2020, 8 (02) :E191-E203
[3]   Are 20 human papillomavirus types causing cervical cancer? [J].
Arbyn, Marc ;
Tommasino, Massimo ;
Depuydt, Christophe ;
Dillner, Joakim .
JOURNAL OF PATHOLOGY, 2014, 234 (04) :431-435
[4]   Screening and management of preinvasive lesions of the cervix: Good clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI) [J].
Bhatla, Neerja ;
Singhal, Seema ;
Saraiya, Usha ;
Srivastava, Shikha ;
Bhalerao, Sarita ;
Shamsunder, Saritha ;
Chavan, Niranjan ;
Basu, Partha ;
Purandare, C. N. ;
Agarwal, P. ;
Arora, M. ;
Bhatla, N. ;
Basu, P. ;
Bhalerao, S. ;
Batra, S. ;
Banerjee, D. ;
Chavan, N. ;
Dhorepatil, B. ;
Gupta, B. ;
Gandhi, G. ;
Gupta, K. ;
Ganesh, P. ;
Joshi, S. ;
Kriplani, A. ;
Khanna, R. ;
Kumar, S. ;
Maheshwari, A. ;
Meena, J. ;
Nayak, B. ;
Natarajan, J. ;
Pai, R. ;
Pathak, R. ;
Prabhu, R. B. ;
Peedicayil, A. ;
Rajaram, S. ;
Sekhon, R. ;
Shamsunder, S. ;
Srivastava, S. ;
Singh, U. ;
Singhal, S. ;
Saraiya, U. ;
Zutshi, V. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2020, 46 (02) :201-214
[5]   High-risk HPV-positive and-negative high-grade cervical dysplasia: Analysis of 5-year outcomes [J].
Bogani, Giorgio ;
Sopracordevole, Francesco ;
Di Donato, Violante ;
Ciavattini, Andrea ;
Ghelardi, Alessandro ;
Lopez, Salvatore ;
Simoncini, Tommaso ;
Plotti, Francesco ;
Casarin, Jvan ;
Serati, Maurizio ;
Pinelli, Ciro ;
Valenti, Gaetano ;
Bergamini, Alice ;
Gardella, Barbara ;
Dell'acqua, Andrea ;
Monti, Ermelinda ;
Vercellini, Paolo ;
Fischetti, Margherita ;
D'ippolito, Giovanni ;
Aguzzoli, Lorenzo ;
Mandato, Vincenzo D. ;
Carunchio, Paola ;
Carlinfante, Gabriele ;
Giannella, Luca ;
Scaffa, Cono ;
Falcone, Francesca ;
Borghi, Chiara ;
Ditto, Antonino ;
Malzoni, Mario ;
Giannini, Andrea ;
Salerno, Maria Giovanna ;
Liberale, Viola ;
Contino, Biagio ;
Donfrancesco, Cristina ;
Desiato, Michele ;
Perrone, Anna Myriam ;
Dondi, Giulia ;
De Iaco, Pierandrea ;
Chiappa, Valentina ;
Ferrero, Simone ;
Sarpietro, Giuseppe ;
Matarazzo, Maria G. ;
Cianci, Antonio ;
Bosio, Sara ;
Ruisi, Simona ;
Guerrisi, Rocco ;
Brusadelli, Claudia ;
Mosca, Lavinia ;
Lagana, Antonio Simone ;
Tinelli, Raffaele .
GYNECOLOGIC ONCOLOGY, 2021, 161 (01) :173-178
[6]   HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women [J].
Bruno, Maria Teresa ;
Ferrara, Martina ;
Fava, Valentina ;
Rapisarda, Agnese ;
Coco, Angela .
VIROLOGY JOURNAL, 2018, 15
[7]   Recurrent respiratory papillomatosis: current and future perspectives [J].
Carifi, Marco ;
Napolitano, Domenico ;
Morandi, Morando ;
Dall'Olio, Danilo .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 :731-738
[8]   Expression of human papillomavirus E6 and E7 oncoprotein mRNA in women with low-grade squamous intraepithelial lesions or less [J].
Casagrande, D. C. ;
Ribalta, J. C. L. ;
Leite, K. D. P. F. ;
Schimidt, M. ;
Speck, N. M. D. G. .
GENETICS AND MOLECULAR RESEARCH, 2016, 15 (01)
[9]   A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer [J].
Castle, Philip E. ;
Dockter, Janel ;
Giachetti, Cristina ;
Garcia, Francisco A. R. ;
McCormick, Mary Kay ;
Mitchell, Amy L. ;
Holladay, E. Blair ;
Kolk, Daniel P. .
CLINICAL CANCER RESEARCH, 2007, 13 (09) :2599-2605
[10]   RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus [J].
Cattani, Paola ;
Siddu, Alessia ;
D'Onghia, Sara ;
Marchetti, Simona ;
Santangelo, Rosaria ;
Vellone, Valerio G. ;
Zannoni, Gian Franco ;
Fadda, Giovanni .
JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) :2136-2141